Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne D Hall

Showing results (31-40 of 185) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|July 1, 2008
Oral substitution treatments for opioid dependenceWayne D Hall, Richard P Mattick
The Medical Journal of Australia|August 7, 2012
Is the non-medical use of prescription stimulants a problem in Australia?Jayne C Lucke, Wayne D Hall
Drug and Alcohol Review|May 8, 2010
Smokeless tobacco products: Unrecognised regulatory and policy opportunitiesCoral E Gartner, Wayne D Hall
Addiction (Abingdon, England)|January 15, 2008
Explaining the convergence of male and female smoking prevalence in AustraliaKatherine I Morley, Wayne D Hall
Addiction (Abingdon, England)|November 9, 2010
The enhancement use of neuropharmaceuticals: more scepticism and caution neededWayne D Hall, Jayne C Lucke
Addiction (Abingdon, England)|July 20, 2019
Commentary on Burgard et al. (2019): Wastewater based estimates of the size of illicit markets for psychoactive drugsJake W O'Brien, Wayne D Hall
The Medical Journal of Australia|January 22, 2008
Should Australia lift its ban on low nitrosamine smokeless tobacco products?Coral E Gartner, Wayne D Hall
Drug and Alcohol Review|April 5, 2011
Smokeless tobacco use in AustraliaCoral E Gartner, Wayne D Hall
Tobacco Control|April 3, 2012
Is the socioeconomic gap in childhood exposure to secondhand smoke widening or narrowing?Coral E Gartner, Wayne D Hall
Addiction (Abingdon, England)|July 22, 2014
Response to Hser et al. (2014): The necessity for more and better data on the global epidemiology of opioid dependenceLouisa Degenhardt, Bradley Mathers, Wayne D Hall
Pageof 19

Showing results (31-40 of 185) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|July 1, 2008
Oral substitution treatments for opioid dependenceWayne D Hall, Richard P Mattick
The Medical Journal of Australia|August 7, 2012
Is the non-medical use of prescription stimulants a problem in Australia?Jayne C Lucke, Wayne D Hall
Drug and Alcohol Review|May 8, 2010
Smokeless tobacco products: Unrecognised regulatory and policy opportunitiesCoral E Gartner, Wayne D Hall
Addiction (Abingdon, England)|January 15, 2008
Explaining the convergence of male and female smoking prevalence in AustraliaKatherine I Morley, Wayne D Hall
Addiction (Abingdon, England)|November 9, 2010
The enhancement use of neuropharmaceuticals: more scepticism and caution neededWayne D Hall, Jayne C Lucke
Addiction (Abingdon, England)|July 20, 2019
Commentary on Burgard et al. (2019): Wastewater based estimates of the size of illicit markets for psychoactive drugsJake W O'Brien, Wayne D Hall
The Medical Journal of Australia|January 22, 2008
Should Australia lift its ban on low nitrosamine smokeless tobacco products?Coral E Gartner, Wayne D Hall
Drug and Alcohol Review|April 5, 2011
Smokeless tobacco use in AustraliaCoral E Gartner, Wayne D Hall
Tobacco Control|April 3, 2012
Is the socioeconomic gap in childhood exposure to secondhand smoke widening or narrowing?Coral E Gartner, Wayne D Hall
Addiction (Abingdon, England)|July 22, 2014
Response to Hser et al. (2014): The necessity for more and better data on the global epidemiology of opioid dependenceLouisa Degenhardt, Bradley Mathers, Wayne D Hall
Pageof 19